Sensipar (cinacalcet), a new drug for dialysis patients
December 2004
Health Canada has just approved Sensipar (cinacalcet), a new drug for dialysis patients.
Chronic kidney disease leads to high serum phosphate...low vitamin D levels...and low serum calcium.
This signals the parathyroid glands to pump out more parathyroid hormone.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive